rs11176013

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198578.4(LRRK2):​c.4911A>G​(p.Lys1637Lys) variant causes a synonymous change. The variant allele was found at a frequency of 0.558 in 1,608,610 control chromosomes in the GnomAD database, including 252,397 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 24558 hom., cov: 32)
Exomes 𝑓: 0.56 ( 227839 hom. )

Consequence

LRRK2
NM_198578.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 4.58

Publications

45 publications found
Variant links:
Genes affected
LRRK2 (HGNC:18618): (leucine rich repeat kinase 2) This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
LRRK2 Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 12-40320071-A-G is Benign according to our data. Variant chr12-40320071-A-G is described in ClinVar as Benign. ClinVar VariationId is 39199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.675 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRK2NM_198578.4 linkc.4911A>G p.Lys1637Lys synonymous_variant Exon 34 of 51 ENST00000298910.12 NP_940980.4 Q5S007Q17RV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRK2ENST00000298910.12 linkc.4911A>G p.Lys1637Lys synonymous_variant Exon 34 of 51 1 NM_198578.4 ENSP00000298910.7 Q5S007

Frequencies

GnomAD3 genomes
AF:
0.567
AC:
86053
AN:
151726
Hom.:
24541
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.588
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.630
Gnomad ASJ
AF:
0.553
Gnomad EAS
AF:
0.482
Gnomad SAS
AF:
0.696
Gnomad FIN
AF:
0.531
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.545
Gnomad OTH
AF:
0.557
GnomAD2 exomes
AF:
0.576
AC:
143530
AN:
249074
AF XY:
0.576
show subpopulations
Gnomad AFR exome
AF:
0.586
Gnomad AMR exome
AF:
0.664
Gnomad ASJ exome
AF:
0.552
Gnomad EAS exome
AF:
0.476
Gnomad FIN exome
AF:
0.536
Gnomad NFE exome
AF:
0.544
Gnomad OTH exome
AF:
0.563
GnomAD4 exome
AF:
0.557
AC:
810800
AN:
1456766
Hom.:
227839
Cov.:
37
AF XY:
0.560
AC XY:
405490
AN XY:
724696
show subpopulations
African (AFR)
AF:
0.587
AC:
19509
AN:
33252
American (AMR)
AF:
0.659
AC:
29238
AN:
44372
Ashkenazi Jewish (ASJ)
AF:
0.554
AC:
14437
AN:
26044
East Asian (EAS)
AF:
0.479
AC:
18942
AN:
39572
South Asian (SAS)
AF:
0.688
AC:
58848
AN:
85532
European-Finnish (FIN)
AF:
0.540
AC:
28800
AN:
53348
Middle Eastern (MID)
AF:
0.502
AC:
2875
AN:
5728
European-Non Finnish (NFE)
AF:
0.545
AC:
604358
AN:
1108706
Other (OTH)
AF:
0.561
AC:
33793
AN:
60212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
18230
36460
54689
72919
91149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17118
34236
51354
68472
85590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.567
AC:
86120
AN:
151844
Hom.:
24558
Cov.:
32
AF XY:
0.570
AC XY:
42262
AN XY:
74196
show subpopulations
African (AFR)
AF:
0.588
AC:
24370
AN:
41426
American (AMR)
AF:
0.631
AC:
9614
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.553
AC:
1918
AN:
3466
East Asian (EAS)
AF:
0.482
AC:
2486
AN:
5162
South Asian (SAS)
AF:
0.695
AC:
3356
AN:
4828
European-Finnish (FIN)
AF:
0.531
AC:
5602
AN:
10542
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.545
AC:
37019
AN:
67876
Other (OTH)
AF:
0.554
AC:
1168
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1916
3831
5747
7662
9578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.563
Hom.:
23219
Bravo
AF:
0.571
Asia WGS
AF:
0.591
AC:
2047
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal dominant Parkinson disease 8 Benign:2Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.3
DANN
Benign
0.62
PhyloP100
4.6
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11176013; hg19: chr12-40713873; COSMIC: COSV54153519; COSMIC: COSV54153519; API